Gilead Shares Tumble On Drug Warning; Baird Says Buy

By: via Benzinga
Two drugs that account for more than half of Gilead Sciences, Inc.'s (NASDAQ: GILD) sales may also cause abnormally slow ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.